According to Reneo Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -ยฃ1.22. In 2022 the company made an earnings per share (EPS) of -ยฃ1.59 a decrease over its 2021 EPS that were of -ยฃ1.25.